Go‐Won Choi

Cancer Research Institute

Papers

1

Total Citations

3

H-Index

1

About

Dr. Go-Won Choi is a pioneering pancreatic surgeon whose research focuses on advancing minimally invasive surgical techniques for pancreatic cancer, particularly through robot-assisted approaches. His landmark study, "Long-term oncologic outcomes of robot-assisted pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic cancer" (2025), represents a critical contribution to the field by addressing the longstanding gap in evidence regarding the long-term oncological efficacy of robotic surgery. While this work has already garnered 3 citations in its early publication, its significance lies in providing the first robust comparative analysis of long-term survival outcomes between robot-assisted and open pancreaticoduodenectomy for pancreatic cancer patients. Dr. Choi's research directly confronts the central question in pancreatic surgery: whether the short-term benefits of minimally invasive techniques can be achieved without compromising oncological outcomes. His work has important implications for surgical decision-making and patient counseling, potentially expanding the adoption of robotic approaches in pancreatic cancer treatment. By systematically evaluating both surgical and oncological endpoints, Dr. Choi is helping to establish evidence-based guidelines for the role of robotic surgery in one of the most challenging oncological procedures.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Long-term oncologic outcomes of robot-assisted pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic cancer
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Cancer Research Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago